1Wang YF,Chung KH,Chung TH,et al.p16INK4 and p15INK4d alteration in primary gynecologic malignancy[].Gynecologic Oncology.1997
2Schmitz MJ,Hendrieks DT,Farley J,et al.P27 and cyclin D1 abnormalities in uterine serous carcinomas[].Gynecologic Oncology.2000
3Shimizu M,Saitch Y,Itoh H.Immunohistochemical staining of H-ras oncogenic product, benign and malignant human pancreatic tissues[].Human Pathology.1990
4Friberg LG,Noren H,Deiie U.Prognostic value of DNA ploid and phase fraction in endometrial cancer stage Ⅰand Ⅱ: a prospective 5-year survival study[].Gynecologic Oncology.1994
5Pfister J,Kommoss F,Sauerbrei W,et al.Prognostic value of DNA ploid and S-phase fraction in stage I endometrial carcinoma[].Gynecologic Oncology.1995
3Yang L, Parkin DM, Li LD et al. Estimation and projection of the nation profile of cancer mortality in China : 1991 - 2005. Br J Cancer,2004, 90:2157-2166
4Stenkvist B, Soderstorm J. Reasons for cervical cancer despite extensive screening. J Med Screen, 1996, 3 (4) : 204-207
5Hutchinson M, Fertitta L, Goldbaum B et al. Cervex - Brush and cytobrush comparison of their ability to sample abnormal cells for cervical smers. J repord Med, 1991, 36 (8) : 581 -586
